Agneta Svedberg
Förmögenhet: 1 M $ per 2026-05-31
Förmögenhet: 1 M $ per 2026-05-31
Agneta Svedberg is currently working as the VP-Clinical Development & Pharmacovigilance at Camurus AB since 2015.
Prior to this, she held positions as the Chief Executive Officer at Cantargia AB, Manager at Pharmacia & Upjohn, Inc., Principal at Oncotelic Therapeutics, Inc., Chief Operating Officer & Senior Vice President at Zealand Pharma A, and Senior Vice President-Clinical Development at Genmab, Inc. Ms. Svedberg has a graduate degree from the University of Lund and holds an MBA from Lund University School of Economics & Management and Executive Foundation Lund.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CAMURUS AB 0,04 % | 2025-09-15 | 22 987 ( 0,04 % ) | 1 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| CAMURUS AB | Teknisk/Vetenskaplig/F&U Direktör | - |
| Företag | Position | Slut |
|---|---|---|
| CANTARGIA AB | Verkställande Direktör | - |
| ZEALAND PHARMA A/S | Verksamhetschef | - |
| ONCOTELIC THERAPEUTICS, INC. | Företagsledare/Principal | - |
Pharmacia & Upjohn, Inc.
Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Företagsledare/Principal | - |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Pharmacia & Upjohn, Inc.
Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Oncotelic Therapeutics, Inc.
Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Commercial Services |
Cantargia AB
Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Lund University School of Economics & Management
Lund University School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Executive Foundation Lund
Executive Foundation Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån